Skip to content
HomeLatest newsWhat you need to know about Johnson & Johnson’s 2019 second-quarter earnings
FINAL LEDE- What You Need to Know About Johnson & Johnson's 2019 Second-Quarter Earnings-Q2 2019 earnings

What you need to know about Johnson & Johnson’s 2019 second-quarter earnings

Check out this infographic breakdown of the company’s second-quarter 2019 performance, with key highlights from its consumer, pharmaceutical and medical devices businesses.

Share Article
share to
Inset - Quarterly Earnings Ribbon

This morning, Johnson & Johnson shared its second-quarter performance.

Since its founding in 1886, the company has grown to become one of the world’s largest and most broadly based healthcare companies, with approximately 135,000 employees across the globe working every day to help change the trajectory of health for humanity.

“Our solid second-quarter results can be attributed to the dedication and hard work of our Johnson & Johnson colleagues around the world, who perpetually strive to bring differentiated healthcare solutions to the most pressing unmet medical needs,” says Joe Wolk, Executive Vice President and Chief Financial Officer, Johnson & Johnson. “As we remain focused on delivering value to all of our stakeholders, we will continue to optimize our portfolio to ensure we make progress against our long-term strategies. Our results during the first half of this year reaffirm our confidence in our 2019 outlook, and position us well to invest for continued success in the future.”

For more details about the company’s second-quarter 2019 results, and to read a comment from Chairman and Chief Executive Officer Alex Gorsky, here’s an infographic that highlights key stats.

2019 Q2 Earnings infographic

Johnson & Johnson’s 2019 2nd-Quarter Earnings

Read the earnings press release, which includes full financial details for the second quarter of the year.

Want to see more company earnings information? Find several years of Johnson & Johnson’s quarterly and full-year results here.

More from Johnson & Johnson

What to know about We All Belong: 2023 DEI Impact Review

The annual report details how Johnson & Johnson is harnessing the power of diversity, equity and inclusion to provide better care around the world.

Giving the gift of sight

In Kenya, around 1.5 million people—including children—contend with visual impairment or blindness. Sight For Kids, Johnson & Johnson’s global eye-care partnership, is devoted to changing these stats, one vision screening at a time.

Inside the development of a revolutionary treatment for blood cancers

In 2014, a Johnson & Johnson therapy gained approval for the treatment of a type of B-cell malignancy—increasing survival rates and changing the way scientists approach cancer treatment. These 8 milestone moments tell the transformational story.
You are now leaving The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.